Connect with us

Published

on

Due to the imminent threat of climate change and expected legal measures, companies across different sectors are increasingly driven to set and actively pursue sustainability objectives.

The pharmaceutical sector, faced with rising stakeholder expectations and tightening regulations, is accelerating efforts to reduce its environmental impact. Several major players in the industry have committed to achieving net-zero emissions as their climate sustainability target. These leading pioneers are blazing the trail by implementing policies and undertaking initiatives, including the purchase of carbon credits, to accomplish this ambitious objective.

 

The pharmaceutical industry’s carbon footprint

The pharmaceutical sector is a significant contributor to global emissions. If it were a country, its carbon footprint would rank 9th in the world. Energy-intensive manufacturing processes, extensive distribution networks, and greenhouse gas-emitting propellants in inhalers drive up the industry’s climate impacts. Experts urge pharmaceutical companies to act, as unmitigated warming could strain global health systems and hinder access to vital medications.

While daunting, the mission is not impossible. Industries like tech and retail are demonstrating that reaching net-zero is within grasp. Google aims to run entirely on carbon-free energy by 2030. IKEA plans to become climate positive by 2030 by reducing more greenhouse gas emissions than its value chain emits. These commitments raise the bar for pharmaceutical companies to take equally bold climate action.

Major industry players are stepping up. AstraZeneca, Novartis, and Takeda have set ambitious net-zero targets, while investing in renewable energy, green chemistry innovation, and carbon removal. Their efforts are having ripple effects as peers follow suit. With collaboration and persistence, the pharmaceutical industry can curb its emissions in line with climate science.

 

AstraZeneca’s U$1BN of climate commitments

With over $26 billion in annual revenue, British-Swedish firm AstraZeneca is one of the world’s largest pharmaceutical companies. It manufactures blockbuster treatments ranging from diabetes to oncology medications.

In 2020, AstraZeneca announced its Ambition Zero Carbon strategy, aiming to achieve carbon neutrality across its entire value chain by 2030. This bold pledge puts AstraZeneca at the vanguard of climate action in pharma.

To meet its goal, AstraZeneca is transitioning to 100% renewable electricity at its sites by 2025. It is also optimizing manufacturing to curb emissions, while partnering with suppliers to reduce their carbon footprints. Further, AstraZeneca plans to eliminate fossil fuel vehicles from its fleet by 2030.

Beyond its operations, AstraZeneca is developing a portfolio of over $1 billion in green investments. These include carbon removal and storage solutions expected to offset about 2.5 million tonnes of CO2 annually by 2025.

AstraZeneca’s commitment is spurring the industry to accelerate sustainability initiatives. Being the pioneer in the pharmaceutical industry to establish a bold net-zero objective that encompasses its entire value chain, AstraZeneca is setting a remarkable example that its competitors will have to strive to emulate.

 

Novartis to use 100% renewable energy within 2023

Headquartered in Switzerland, Novartis is a leading global medicines company with over $48 billion in 2021 revenue. Its therapeutic areas span eye care, immunology, and cardiovascular treatments.

In 2021, Novartis announced its aim to achieve carbon neutrality across Scopes 1, 2, and 3 by 2040. Scope 1 and 2 cover direct emissions from Novartis’ operations, while Scope 3 includes indirect emissions across its supply chain.

Novartis’ environmental policies are publicly available on the internet. The company has made meeting its net-zero ambition a top priority, with a strong and focused approach in four crucial areas: sourcing renewable electricity, enhancing energy efficiency, promoting innovative green chemistry, and investing in carbon removal offsets.

Already, Novartis sources 80% of its electricity from renewables. It is also optimizing production processes, deploying automation, and modifying fleet vehicles to curb emissions. The company is on track to source 100% of its power from renewables by years’ end of 2023.

Additionally, Novartis is pioneering molecular design techniques to develop medicines with lower environmental impacts. Furthermore, the company is actively investing in projects that focus on nature-based carbon removal, such as collaborating with Carbon Direct to expand the implementation of carbon forestry offsets.

By setting and working toward net-zero science-based targets, Novartis is positioning itself as a leader in green pharmaceutical manufacturing. Its multipronged approach can serve as a model for other companies.

 

Takeda Pharmaceuticals shows the way for Asia

Japan’s largest pharmaceutical company, Takeda Pharmaceutical generates over $30 billion in annual revenue from medicines treating conditions from cancer to rare diseases.

In 2021, Takeda announced its commitment to achieving net-zero greenhouse gas emissions by 2040. It is working to reduce and offset its entire carbon footprint, including Scope 3 emissions from its supply chain.

Takeda is achieving its goal by increasing renewable electricity usage, improving energy efficiency at its sites, electrifying its vehicle fleet, and reducing emissions from business travel. It aims to cut Scopes 1 and 2 emissions 46% by 2030.

Takeda is also collaborating with pharmaceutical industry partners and suppliers to curb emissions across its value chain under the Pharmaceutical Supply Chain Initiative. And it plans to utilize carbon removal offsets for hard-to-abate emissions.

Takeda’s pledge to achieve net-zero marks a groundbreaking moment for the pharmaceutical industry in Asia and beyond, as they lead the charge towards comprehensive decarbonization. Its 2040 target and interim science-based milestones demonstrate meaningful leadership.

 

Pharma’s challenges in reaching net-zero

Despite strong commitments from sustainability front-runners, achieving net-zero emissions poses complex challenges for pharmaceutical companies. Many production processes inherently rely on fossil fuels as heat sources and for transporting materials. Companies need major capital investments to transition these operations to clean energy alternatives.

Pharmaceutical distribution and long, complex supply chains also make emissions reductions difficult. Cold chain storage and last-mile delivery result in substantial greenhouse gas outputs. Meanwhile, developing green chemistry solutions requires years of research and development, along with new manufacturing infrastructure. These costs can be prohibitive. Further, credibly offsetting all residual emissions will necessitate scaled up, verifiable carbon removal markets. Technical and economic hurdles remain for many offset types.

 

Overcoming Challenges

While obstacles exist, experts emphasize they can be solved through collaboration, innovation, and policy action.

Companies can join forces and share their knowledge and resources through initiatives like the Pharmaceutical Supply Chain Initiative. This collaboration enables them to not only expand their renewable energy procurement, but also boost their efficiency and make strides in green chemistry.

Governments can help by offering incentives for clean technology investments and funding research into pharmaceutical process improvements.

International cooperation can accelerate decarbonization of global supply chains. And standardized offset methodologies will ensure carbon removal credits have integrity.

Ultimately, reaching net-zero will depend on persistence, investment, and cross-industry partnership. But the health and environmental benefits make it imperative for pharmaceutical companies to see it through.

 

Opportunities from net-zero efforts

Pursuing net-zero also opens up opportunities for pharmaceutical companies to add business value, beyond environmental benefits. Optimizing processes for energy efficiency provides cost savings from reduced power consumption and heating needs. Streamlining supply chains also cuts costs over the long-term.

First movers on net-zero can boost their reputations with consumers and investors, who increasingly prioritize sustainability. These companies may have better talent recruitment and retention.

Developing and marketing lower carbon medicines can become a competitive advantage. Doctors and health systems are paying more attention to the climate footprint of drugs.

AstraZeneca’s partnerships have the potential to unlock opportunities for companies to venture into the burgeoning green investment markets. Through these collaborations, businesses can not only contribute to the sustainability of our planet but also reap financial benefits by investing in carbon removal and renewable energy projects.

Finally, building climate resilience helps ensure business continuity as physical impacts of climate change accelerate.

 

Government policy propels climate action

Governments are ramping up policies aimed at decarbonizing pharmaceutical value chains through incentives and requirements.

The Inflation Reduction Act of 2022 in the United States presents an extraordinary opportunity, providing over $60 billion in incentives dedicated to fostering energy efficiency, electrification, and groundbreaking advancements in green chemistry. This can offset costs for companies pursuing these strategies.

The EU’s pharmaceutical strategy aims to make drug manufacturing and distribution more sustainable by implementing green product design and procurement requirements. This will help reduce emissions.

India released a roadmap in 2022 pushing pharmaceutical companies to adopt renewable energy and assess Scope 3 climate impacts. It aims to help India meet its national climate targets.

Such policies encourage pharmaceutical companies to take ownership of their emissions and are likely to expand as more governments declare net-zero commitments.

 

The Road Ahead

While the 2030s and 2040s may seem like distant milestones, reaching net-zero requires immediate action across pharmaceutical supply chains. Industry leaders have provided a blueprint – including renewable energy procurement, distribution optimization, green chemistry, and carbon removal.

New technologies and nature-based solutions are expanding decarbonization opportunities. With collective willpower, strategic investment, and transparent reporting, net-zero is within the pharmaceutical industry’s reach. All stakeholders must maintain pressure and hold firms accountable to their pledges for a sustainable future.

 

Photo credit

Photo by Myriam Zilles on Unsplash

Carbon Footprint

ArcelorMittal Confirms $1.5 Billion Low-Carbon Steel Investment in France

Published

on

ArcelorMittal Confirms $1.5 Billion Low-Carbon Steel Investment in France

ArcelorMittal will invest €1.3 billion (about $1.5 billion) to build a new electric arc furnace (EAF) at its steel site in Dunkirk, France. The company said the project marks a major step in cutting emissions from its French steel production.

The steelmaker announced the decision as French President Emmanuel Macron visited the Dunkirk site. ArcelorMittal said it now has more confidence to move forward because of recent policy and market changes in Europe and France. CEO Geert van Poelvoorde said,

“The decision to proceed with building an EAF in ArcelorMittal Dunkirk, to produce low-carbon emissions steel at scale for our customers, has been made possible because we now have the conditions in place to make this project a success…We will now focus on steering the Dunkirk EAF project to completion and commercial success.”

The EAF is scheduled to start up in 2029. It will have a capacity of 2 million tonnes of steel per year. 

A 2M-Tonne Shift Toward Scrap-Based Steel

Electric arc furnaces make steel mainly by melting scrap steel. They can also use low-carbon inputs like HBI/DRI (hot briquetted iron / direct reduced iron) mixed with hot metal. ArcelorMittal said its Dunkirk EAF will use a mix of scrap, HBI/DRI, and hot metal.

The company also gave a clear emissions estimate. It said the new EAF will emit about 0.6 tonne of CO₂ per tonne of steel and deliver three times less CO₂ than steel made in a blast furnace route.

This matters because steel is a hard sector to decarbonize. The industry produces significant CO₂e emissions, due to energy-intensive processes and heavy fossil fuel use. 

Per World Steel Association, the steel industry produces ~3 billion tonnes of CO₂ annually, accounting for ~9% of global emissions. The industry emits an average of 1.89 tonnes CO₂ per tonne in 2020. Producing one tonne of steel generates 1.7-1.8 tonnes of CO₂ on average, depending on technology use as seen below.

steel industry carbon emissions
Data source: World Steel Association

How Will France Support the Investment?

ArcelorMittal said part of the project will receive public support through Energy Efficiency Certificates (CEE). CEE is a regulatory mechanism in France that promotes energy savings and CO₂ reductions. The company said the support amount will represent 50% of the €1.3 billion investment.

The steelmaker also pointed to a key energy step in France. It said it recently signed a contract with EDF to secure a long-term supply of low-carbon, competitive electricity. The company described this as a major part of its energy strategy in France.

Electricity supply is critical for EAFs. The carbon benefit of an EAF depends heavily on how clean the grid is and how stable power prices are over time.

Why Did ArcelorMittal Invest in Bunkirk?

ArcelorMittal said three developments gave it confidence to confirm the Dunkirk investment.

  • Import Controls

First, it cited new European Commission proposals to limit unfair imports through a Tariff Rate Quota (TRQ) mechanism. ArcelorMittal said this approach would limit import quantities and impose additional duties if imports exceed set limits.

  • CBAM

Second, it pointed to proposed reforms to the EU’s Carbon Border Adjustment Mechanism (CBAM). ArcelorMittal said it expects these measures—if fully implemented—to restore “fair and competitive conditions” in the European steel market.

CBAM is the EU’s tool to apply a carbon price to certain carbon-intensive goods entering the EU. The European Commission says CBAM’s transitional phase runs from 2023 to 2025, and the definitive regime starts in 2026.

ArcelorMittal’s message was direct. It said it is important to implement the TRQ and adjust CBAM to close remaining loopholes as quickly as possible.

  • EDF Deal

Third, it highlighted its EDF electricity deal as another factor supporting the project.

€500M Bet on Electrification Demand

ArcelorMittal also highlighted another major investment near Dunkirk. At its Mardyck plant, close to Dunkirk, the company said it is starting up a new electrical steel production unit this quarter.

It said the company invested €500 million in this facility. ArcelorMittal described it as its largest investment in Europe in the last 10 years, excluding decarbonization projects.

Electrical steel is used in electric motors and other electrification applications. ArcelorMittal said the new plant supports the electrification of industrial and automotive uses. This point matters for demand.

Steelmakers often need clearer long-term demand signals for low-carbon materials before committing large capital to new production routes. 

From Blast Furnaces to EAFs: ArcelorMittal’s Broader Decarbonization Program

ArcelorMittal says it remains committed to reaching net-zero emissions by 2050. The company set this as a group-wide goal in 2020.

ArcelorMittal net zero or decarbonization roadmap
Source: ArcelorMittal

In its latest sustainability update, ArcelorMittal’s absolute emissions for its 2024 operating perimeter are almost 50% lower than its 2018 operating perimeter. The steel manufacturer further said it has invested $1 billion in decarbonization projects over that period.

The company is also shifting more steel production to the electric arc furnace (EAF) route. EAF production accounted for about a quarter of its global steelmaking in 2024, up from 19% in 2018.

In Europe, ArcelorMittal is moving ahead with several EAF-led projects. It said it started construction of a 1.1 million-tonne EAF at its long products plant in Gijón, Spain, which it expects will cut emissions by 1 million tonnes of CO₂e. It is also increasing output at Sestao, Spain, to 1.6 million tonnes by 2026, using two EAFs.

ArcelorMittal markets its low-carbon products under the XCarb® brand. The company said it can deliver low-carbon steel with a footprint as low as 300 kg CO₂ per tonne of steel, and it expected XCarb sales to rise to around 400,000 tonnes in the year it reported.

More notably, the company already operates an industrial-scale carbon capture and utilization (CCU) facility at Ghent, Belgium, with two additional pilots underway at the same site. 

Carbon Pricing and Competitiveness Reshape Steel

Steel decarbonization requires major capital and new infrastructure. It also needs policy support that reduces carbon leakage risk and helps companies compete with lower-cost imports.

The EU’s CBAM design aims to put a fair carbon price on imports and reduce the incentive to shift production outside the EU. The Commission notes that CBAM is also aligned with the phase-out of free allowances under the EU ETS to support industrial decarbonization.

At the same time, the steel sector still needs faster progress on emissions cuts. The IEA notes that steel emissions and emissions intensity need to fall by about 25% by 2030—around 3% per year—to get on track for net zero by mid-century.

ArcelorMittal’s Dunkirk EAF fits this direction. It shifts part of production toward a lower-emissions process and signals confidence that market rules are moving toward stronger climate and competitiveness safeguards.

Execution Phase: Can Policy and Profit Align?

ArcelorMittal said it will now focus on delivering the Dunkirk EAF project through to completion and commercial success.

The company also said it will review the possibility of building further EAFs elsewhere in Europe, but it plans to take a cautious approach based on its “economic decarbonisation” strategy.

For France, the project adds to broader efforts to keep heavy industry competitive while cutting emissions. Meanwhile, it reflects a wider shift toward low-carbon industrial investment for Europe backed by border measures, market defenses, and energy contracts.

For customers, the key outcome is supply. A 2-million-tonne EAF could provide lower-carbon steel at scale, starting in 2029, if the project stays on schedule and the policy measures ArcelorMittal cited take effect as planned.

The post ArcelorMittal Confirms $1.5 Billion Low-Carbon Steel Investment in France appeared first on Carbon Credits.

Continue Reading

Carbon Footprint

Trump EPA’s Largest Climate Deregulation: What the 2009 “Endangerment Finding” Repeal Means for U.S. Emissions and the EV Market

Published

on

On February 12, President Donald Trump and the U.S. Environmental Protection Agency (EPA) Administrator Lee Zeldin announced what they called the largest deregulation in U.S. history in the White House’s Roosevelt Room.

The EPA finalized a rule that removes the 2009 Greenhouse Gas (GHG) Endangerment Finding. The Obama administration created this finding, and it gave the federal government the legal authority to regulate greenhouse gas emissions under the Clean Air Act for more than a decade.

The new rule also removes all federal greenhouse gas standards for cars, trucks, and engines built from model year 2012 through 2027 and beyond. In addition, the EPA ended compliance credits tied to certain technologies, including start-stop systems.

In short, the administration rolled back the key rule that supported federal climate regulations on vehicles.

The Role of the 2009 Endangerment Finding

In 2009, the EPA said that six major greenhouse gases—including carbon dioxide—harm public health and the environment. The agency concluded that these gases drive climate change and damage air quality. That decision gave the federal government the authority to set emission limits for light-, medium-, and heavy-duty vehicles. It also supported climate rules for power plants and the oil and gas industry.

Because of this finding, the EPA introduced several greenhouse gas standards over the past decade. These rules shaped vehicle design, fuel economy targets, and broader climate policy across multiple sectors.

Why the EPA Repealed It Now

In 2025, the Trump administration began reviewing the 2009 decision. Officials argued that some of the science behind the finding was weaker than originally believed. They also said earlier climate projections were too pessimistic.

Now that the repeal is final, the EPA says it no longer has authority under Section 202(a) of the Clean Air Act to regulate greenhouse gases the way it did before. The agency believes Congress—not federal regulators—should decide major climate policy.

EPA leaders say this move restores a strict reading of the law and ends what they call regulatory overreach. Critics strongly disagree. Many scientists and public health experts argue that the repeal removes an important tool that protects Americans and helps address climate change.

Most importantly, the EPA estimates the final rule will save more than $1.3 trillion. It removes requirements for automakers to measure, report, certify, and comply with federal greenhouse gas standards. The agency says the rollback will lower vehicle prices, expand consumer choice, and reduce transportation costs for families and businesses.

Administrator Zeldin commented,

“The Endangerment Finding has been the source of 16 years of consumer choice restrictions and trillions of dollars in hidden costs for Americans. Referred to by some as the ‘Holy Grail’ of the ‘climate change religion,’ the Endangerment Finding is now eliminated. The Trump EPA is strictly following the letter of the law, returning commonsense to policy, delivering consumer choice to Americans and advancing the American Dream. As EPA Administrator, I am proud to deliver the single largest deregulatory action in U.S. history on behalf of American taxpayers and consumers. As an added bonus, the off-cycle credit for the almost universally despised start-stop feature on vehicles has been removed.”

U.S. Emissions Trends in 2025: Mixed Signals

At a climate crossroads, the United States saw a rebound in greenhouse gas emissions in 2025 after years of overall decline. According to estimates from the Rhodium Group, total U.S. emissions rose about 2.4% in 2025, reaching roughly 5.9 billion tons of CO₂ equivalent—139 million tons higher than in 2024. This uptick ended a two‑year downward trend that had been driven by cleaner energy and transportation shifts.

us emission

Several factors pushed emissions higher: colder winter weather increased demand for heating; rising electricity demand from data centers and cryptocurrency mining boosted fossil fuel use; and higher natural gas prices led utilities to burn more coal. The power sector alone saw a 3.8% rise in emissions, while buildings’ emissions jumped 6.8%. Transportation emissions, the largest U.S. source, remained largely flat, increasing only modestly due to continued adoption of hybrid and electric vehicles.

us emissions

Despite the 2025 increase, total emissions are still below pre‑pandemic levels and well under 2005 baselines—roughly 18% below 2005 levels—showing that long‑term trends toward decarbonization have not entirely reversed yet.

Preliminary sector data from Climate TRACE also indicates that U.S. emissions continued rising throughout 2025, adding more than 71 million tonnes of CO₂ equivalent through the first three quarters of the year.

The EV Market in 2025: Growth and Slowdowns

In contrast to emissions trends, the U.S. electric vehicle (EV) market continued to grow in 2025, though the pace and dynamics evolved. EVs made notable gains in sales and market share, reflecting both consumer demand and industry transitions.

In the first quarter of 2025, nearly 300,000 battery‑electric vehicles were newly registered, marking over a 10% year‑over‑year increase. EVs accounted for about 7.5% of all new car registrations during that period.

By the third quarter, sales surged again. Cox Automotive reported that EV sales jumped nearly 30% year‑over‑year, pushing EV market share to a record 10.5% of total vehicle sales in Q3 2025—a milestone reflecting strong consumer uptake in several segments.

ev sales
source: Cox Automotive

Even so, EV adoption remains far from dominating the U.S. market. Estimates show that electric vehicles comprised around 8–10% of total U.S. new car sales in 2025, with internal‑combustion engine vehicles still accounting for the large majority of the fleet.

Tesla remained the largest EV brand in the U.S. in 2025, holding about 46% market share, though this marked a slight decline from previous years. Rivals like Chevrolet and Hyundai grew their shares, reflecting broader model availability and shifting consumer preferences.

Market analysts also project that by 2025, the U.S. EV market’s size, sales, and technology focus will continue expanding—with battery‑electric vehicles expected to dominate EV segments. The broader EV market size had substantial growth in 2025, with further expansion expected toward the end of the decade.

us ev market

Balancing Regulation, Consumer Choice, and Emissions Goals

EPA officials say that removing federal GHG standards and related compliance credits will lower vehicle costs by about $2,400 per car. This will ease financial pressure on families and businesses and give buyers more choice. The agency calls it a step toward restoring the American Dream, making transportation more affordable without high regulatory costs.

Supporters argue the rollback removes artificial mandates, letting automakers and consumers focus on market-driven solutions. The EPA also ended “off-cycle” credits, which allowed carmakers to meet emission targets with minor technology changes. Critics called these credits gimmicks with little real environmental benefit.

Litigation and Future Policy

Environmental groups, scientists, and several states sharply criticized the move. They warn that it weakens climate action, public health protections, and emission reductions. Many fear that removing these rules while emissions are rising could set back U.S. climate goals.

Legal challenges are expected, with lawsuits likely to block or reverse the repeal. As federal rules change, state policies, corporate commitments, and Congress may play a larger role. Some states have already set carbon standards and EV incentives, creating a patchwork of climate policies across the country.

In conclusion, the 2026 repeal of the GHG Endangerment Finding marks a major shift in U.S. climate policy. With emissions rising and clean technology markets evolving, the country faces tough choices about balancing economic growth, innovation, and climate risk. The coming years will be shaped by lawsuits, state leadership, private investments, and the global move toward low-carbon economies.

The post Trump EPA’s Largest Climate Deregulation: What the 2009 “Endangerment Finding” Repeal Means for U.S. Emissions and the EV Market appeared first on Carbon Credits.

Continue Reading

Carbon Footprint

DECARBON 2026 Concludes with Two Days of Strategic Debate and Practical Decarbonisation Insights

Published

on

Hosted by Shell and held in partnership with Moeve, Fluor, Gasunie, The International Association of Oil & Gas Producers, Repsol, Spiecapag and Germany Trade and Invest, DECARBON 2026 centred on practical decision-making at the intersection of policy, technology and implementation across the oil and gas value chain in Vösendorf, Austria.

On 9 February, the first day opened with an Executive Opening Panel that set the strategic context for DECARBON by linking emissions targets with the operational capabilities required to deliver them. Drawing on perspectives from Petro IT, Shell Austria, Saipem SpA, Austrian Gas Grid Management AG, Chromalox, NEUMAN & ESSER Deutschland GmbH & Co KG and PCK Raffinerie GmbH, the discussion addressed investment priorities, data-driven decision-making and on-site constraints, clarifying why a strategic approach and clearly defined NetZero targets play a central role in modern oil and gas operations.

As Rainer Klöpfer, Country Chair & Managing Director at Shell Austria, emphasised, the conversation around net-zero must account for the full carbon intensity of energy products, spanning production, supply chains and end use. He underlined that operating plans are updated regularly and reflect today’s economic realities, while long-term net-zero targets sit beyond immediate planning cycles and require steady structural progress. This perspective shifted the focus from ambition to execution and naturally opened the floor to the next strategic question: which concrete low-carbon solutions can integrate into existing systems at scale.

This was followed by the Leaders Panel on low-carbon hydrogen as a decarbonisation tool, with contributions from a broad range of energy, infrastructure and technology players, including MOL Group, Eurogas, NextChem, Alléo Energy, Moeve and Italgas Reti. The panel examined hydrogen’s role within decarbonisation strategies and its interaction with existing infrastructure and regulatory frameworks.

Pedro Medina, Hydrogen Technology Manager at Moeve, outlined the company’s transformation of its refineries in San Roque and Palos de la Frontera into diversified energy parks adapted for renewable fuels, including biofuels and green hydrogen. He emphasised Southern Europe’s strong production potential and referred to the development of European hydrogen corridors connecting hubs such as Huelva and Algeciras with

Rotterdam, illustrating how green hydrogen is taking shape as a cross-border value chain within the evolving European energy landscape.

The conversation then continued through two roundtable discussions. The first roundtable on the digital approach to emissions performance brought together representatives from Siemens AG, Gradyent and other industry participants to explore digitalisation, automation and data-driven sustainability initiatives. The next roundtable on institutional readiness, with participants from Wood, OPEC, OGE and others, addressed regulatory risk, compliance requirements and policy developments.

Day One also featured two thematic sessions examining decarbonisation pathways in downstream operations through low-carbon fuels and feedstock, alongside practical levers for emissions reduction in upstream activities, with contributions from companies including TotalEnergies, Chromalox, VEM Sachsenwerk GmbH and others.

It concluded with a gala dinner and prize draw at Casino Baumgarten, located in the heart of Vienna. Live music, a magician’s performance and a gift raffle from BGS Group and participating delegates created a vibrant atmosphere, while conversations continued over dinner in an informal setting that strengthened professional connections.

The second day moved the discussion toward evaluation and optimisation, bringing sharper focus to cost, performance and implementation. During a moderated debate, representatives of Reganosa, Saras, Gas Infrastructure Europe and The Carbon Capture and Storage Association examined the financial implications of decarbonisation and the investment logic behind transition pathways. Roundtable 3 then turned to energy efficiency in downstream, where Fluor, Akselos and other sector specialists shared operational case studies and technical insight. The Congress concluded with a Closing Panel on CCUS, featuring perspectives from Petrofac, DESFA, Worley Comprimo and others, highlighting carbon capture, utilisation and storage within long-term emissions reduction strategies.

Phillip Cooper, Project Director at Petrofac for the Design of the Aramis CCS Pipeline System, summarised the key lesson from project delivery: effective CCS development requires a collaborative and knowledgeable client and FEED team in the room from the outset to ensure alignment and accelerate resolution. He stressed that system engineering across the entire value chain is critical, as the whole system must function as one despite contractual boundaries, and that early involvement of contractors and vendors is essential to understand what the project will realistically cost and to avoid unnecessary cost premiums.

Over the two days, DECARBON 2026 reinforced its role as a closed-door platform for senior executives, technical leaders and policy experts to engage in implementation-oriented dialogue grounded in real operational contexts. More than 180 pre-arranged B2B sessions took place within a structured networking format, coordinated by dedicated personal managers assigned to each delegate. Participants highlighted the productivity and efficiency of these targeted exchanges, with many confirming follow-up discussions and outlining future joint projects.

Registration for DECARBON 2027, taking place on 15-16 February 2027 in Berlin, Germany, is now open. Follow the Congress updates and secure participation in the next edition focused on real-world decarbonisation strategies: https://sh.bgs.group/3ui

The post DECARBON 2026 Concludes with Two Days of Strategic Debate and Practical Decarbonisation Insights appeared first on Carbon Credits.

Continue Reading

Trending

Copyright © 2022 BreakingClimateChange.com